Skip to main content
XAIR
NASDAQ Life Sciences

Beyond Air 确保重大 GPO 交易，扩大 LungFit PH 的访问范围至 2,000 家医院

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
8
Price
$0.738
Mkt Cap
$7.267M
52W Low
$0.667
52W High
$5.842
Market data snapshot near publication time

summarizeSummary

Beyond Air, Inc.宣布其 LungFit® PH 系统与一家顶级 GPO 达成新的全国集团采购协议，自 2026 年 4 月 1 日起生效。这一重要合作伙伴关系将公司的商业范围扩大至近 2,000 家额外的美国医院和医疗系统，建立在现有的 GPO 关系之上。对于最近在其 2025 年 Q3 结果中发布了“持续经营”警告的微型上市公司来说，这一协议是一项重大积极发展，直接解决了收入生成和市场渗透问题，其产品获得 FDA 批准。它为医院采用提供了无气瓶、按需使用的一氧化氮解决方案 LungFit® PH 提供了便利的途径。交易者将密切关注这一扩大访问范围对销售和收入的实际影响，因为公司致力于改善其财务状况。

在该公告发布时，XAIR的交易价格为$0.74，交易所为NASDAQ，所属行业为Life Sciences，市值约为$726.7万。 52周交易区间为$0.67至$5.84。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed XAIR - Latest Insights

XAIR
Apr 24, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Beyond Air Seeks Second Reverse Stock Split to Avoid Nasdaq Delisting, Warns of Total Investment Loss
Sentiment: Negative
View Wiseek Article
XAIR
Apr 15, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Beyond Air Appeals Nasdaq Delisting Notice, Securing Temporary Stay Until May Hearing
Sentiment: Neutral
View Wiseek Article
XAIR
Apr 10, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
9
Beyond Air Faces Nasdaq Delisting Threat Over Sub-$1 Share Price, Plans Appeal
Sentiment: Negative
View Wiseek Article
XAIR
Apr 10, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Beyond Air Faces Imminent Nasdaq Delisting Threat, Ineligible for Standard Compliance Period
Sentiment: Negative
View Wiseek Article
XAIR
Apr 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Beyond Air Announces CEO Transition with Substantial Severance Amidst Going Concern Warning
Sentiment: Negative
View Wiseek Article
XAIR
Apr 01, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Beyond Air Secures Major GPO Deal, Expanding LungFit PH Access to 2,000 Hospitals
Sentiment: Positive
View Wiseek Article
XAIR
Mar 17, 2026, 4:35 PM EDT
Source: GlobeNewswire
Importance Score:
9
Beyond Air Subsidiary Reports Compelling Early Efficacy, Favorable Safety in Phase 1 Cancer Trial
Sentiment: Positive
View Wiseek Article
XAIR
Feb 13, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
9
Beyond Air Reports Q3 Results with Going Concern Warning, Details Recent Capital Raises and Strategic Divestiture
Sentiment: Neutral
View Wiseek Article
XAIR
Feb 10, 2026, 9:00 AM EST
Filing Type: 424B3
Importance Score:
8
Beyond Air Finalizes Registration for Resale of 7.86 Million Shares and Warrants
Sentiment: Negative
View Wiseek Article
XAIR
Feb 02, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Stockholders Approve Equity Incentive Plan, Authorizing 850,000 New Shares
Sentiment: Negative
View Wiseek Article